How many employees work at Kailera?
KBR, Inc. is a prominent global technology and engineering solutions company providing professional services, scientific research, and project execution for government and commercial clients in aerospace, defense, and energy sectors. According to annual corporate reports and workforce analytics, the enterprise maintains an international team of approximately 36,000 to 39,000 employees. The multicultural workforce is distributed across project sites and technical offices worldwide, comprising aerospace engineers, defense contractors, project managers, and environmental scientists.
Related FAQs
Karine Hagen is directly related to Torstein Hagen as his daughter.
A single common share of Kakao Corp. trades at approximately 36,200 South Korean won (KRW) on the Korea Exchange, supported by a total corporate market capitalization exceeding 15.8 trillion won.
Investors residing in the United States who want to purchase shares of Kioxia Holdings Corporation, a major global memory and semiconductor manufacturer, must navigate international accessibility constraints since the company's primary public list...
Companies frequently evaluate initial public offering market conditions before listing their common shares on major public stock exchanges.
Kailera Therapeutics operates as a publicly traded biopharmaceutical enterprise following its initial public offering on the NASDAQ stock exchange under the ticker symbol KLRA.
Kailera Therapeutics maintains full status as a publicly traded corporation, with its common shares listed and actively traded on the NASDAQ exchange.